Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SKYTROFA® safely and effectively. See full prescribing information for SKYTROFA®. SKYTROFA® (lonapegsomatropin-tcgd) for injection, for subcutaneous use Initial U.S. Approval: 2021
Medication labelWhy this: Advisory · dailymed-prescription
SKYTROFA (lonapegsomatropin-tcgd) is a human growth hormone indicated for the: Treatment of pediatric patients 1 year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone (GH). Replacement of endogenous growth hormone in adults with growth hormone deficiency (GHD).
- generic_name
- lonapegsomatropin-tcgd
- product_names
- Lonapegsomatropin-tcgd
- ndc
- 73362-003, 73362-003-02, 73362-003-01, 73362-004, 73362-004-02, 73362-004-01, 73362-005, 73362-005-02, 73362-005-01, 73362-006, 73362-006-02, 73362-006-01, 73362-007, 73362-007-02, 73362-007-01, 73362-008, 73362-008-02, 73362-008-01, 73362-009, 73362-009-02, 73362-009-01, 73362-010, 73362-010-02, 73362-010-01, 73362-011, 73362-011-02, 73362-011-01, 73362-012, 73362-012-02, 73362-012-01, 73362-013, 73362-013-02, 73362-013-01, 73362-014, 73362-014-02, 73362-014-01, 73362-015, 73362-015-02, 73362-015-01, 73362-016, 73362-016-02, 73362-016-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en